TRJN.F Stock Overview

Develops, manufactures, sells, and distributes analytical and life science products and devices in Australia, New Zealand, Malaysia, Japan, the United States, Europe, the Middle East, Africa, and India. More details

TRJN.F fundamental analysis
Snowflake Score
Valuation	3/6
Future Growth	3/6
Past Performance	0/6
Financial Health	5/6
Dividends	0/6

Rewards

Trading at 3.3% below our estimate of its fair value

Earnings are forecast to grow 98.81% per year

Risk Analysis

Shares are highly illiquid

Does not have a meaningful market cap ($158M)

My Notes

Capture your thoughts, links and company narrative

Trajan Group Holdings Limited Competitors

Inotiv

NasdaqCM:NOTV

US$106.1m

Seer

NasdaqGS:SEER

US$136.2m

Akoya Biosciences

NasdaqGS:AKYA

US$123.4m

PhenomeX

NasdaqGS:CELL

US$99.6m

Price History & Performance

Summary of share price highs, lows and changes for Trajan Group Holdings
Historical stock prices
Current Share Price	AU$0.63
52 Week High	AU$0.86
52 Week Low	AU$0.63
Beta	0.70
1 Month Change	0%
3 Month Change	n/a
1 Year Change	n/a
3 Year Change	n/a
5 Year Change	n/a
Change since IPO	-27.17%

Recent updates

Shareholder Returns

	TRJN.F	US Life Sciences	US Market
7D	0%	-2.1%	-2.4%
1Y	n/a	-5.5%	23.4%

Return vs Industry: Insufficient data to determine how TRJN.F performed against the US Life Sciences industry.

Return vs Market: Insufficient data to determine how TRJN.F performed against the US Market.

Price Volatility

Is TRJN.F's price volatile compared to industry and market?
TRJN.F volatility
TRJN.F Average Weekly Movement	n/a
Life Sciences Industry Average Movement	9.2%
Market Average Movement	6.3%
10% most volatile stocks in US Market	16.8%
10% least volatile stocks in US Market	3.1%

Stable Share Price: TRJN.F's share price has been volatile over the past 3 months compared to the US market.

Volatility Over Time: Insufficient data to determine TRJN.F's volatility change over the past year.

About the Company

Founded	Employees	CEO	Website
2011	600	Stephen Tomisich	www.trajanscimed.com

Trajan Group Holdings Limited develops, manufactures, sells, and distributes analytical and life science products and devices in Australia, New Zealand, Malaysia, Japan, the United States, Europe, the Middle East, Africa, and India. The company offers analytical products, including syringes, GC columns and septa, rings, inlet liners, and tubing products; pathology products, consisting of NBF containers, adhesive and frosted microscope slides, coverslips, slide storage trays/mailers, cassette storage boxes, biopsy pads, histology wax plus, microtome blades, and marking dyes and sets, and MiPlatform, a smartphone adapter. It also provides sampling products, comprising septa, caps, liners, crimping tools, well plates and sealing mats, and micro sampling tools, as well as automation systems for the analysis of biological, food, and environmental samples.

Trajan Group Holdings Limited Fundamentals Summary

How do Trajan Group Holdings's earnings and revenue compare to its market cap?
TRJN.F fundamental statistics
Market cap	US$99.04m
Earnings (TTM)	-US$15.84m
Revenue (TTM)	US$96.96m

1.0x

P/S Ratio

-6.3x

P/E Ratio

Is TRJN.F overvalued?

See Fair Value and valuation analysis

Earnings & Revenue

Key profitability statistics from the latest earnings report (TTM)
TRJN.F income statement (TTM)
Revenue	AU$155.02m
Cost of Revenue	AU$95.27m
Gross Profit	AU$59.75m
Other Expenses	AU$85.08m
Earnings	-AU$25.33m

Last Reported Earnings

Jun 30, 2024

Next Earnings Date

n/a

Earnings per share (EPS)	-0.17
Gross Margin	38.55%
Net Profit Margin	-16.34%
Debt/Equity Ratio	42.9%

How did TRJN.F perform over the long term?

See historical performance and comparison

Company Analysis and Financial Data Status

Data	Last Updated (UTC time)
Company Analysis	2024/12/22 19:45
End of Day Share Price	2024/10/09 00:00
Earnings	2024/06/30
Annual Earnings	2024/06/30

Data Sources

The data used in our company analysis is from S&P Global Market Intelligence LLC. The following data is used in our analysis model to generate this report. Data is normalised which can introduce a delay from the source being available.

Package	Data	Timeframe	Example US Source ^*
Company Financials	10 years	Income statement Cash flow statement Balance sheet	SEC Form 10-K SEC Form 10-Q
Analyst Consensus Estimates	+3 years	Forecast financials Analyst price targets	Analyst Research Reports Blue Matrix
Market Prices	30 years	Stock prices Dividends, Splits and Actions	ICE Market Data SEC Form S-1
Ownership	10 years	Top shareholders Insider trading	SEC Form 4 SEC Form 13D
Management	10 years	Leadership team Board of directors	SEC Form 10-K SEC Form DEF 14A
Key Developments	10 years	Company announcements	SEC Form 8-K

^* example for US securities, for non-US equivalent regulatory forms and sources are used.

Unless specified all financial data is based on a yearly period but updated quarterly. This is known as Trailing Twelve Month (TTM) or Last Twelve Month (LTM) Data. Learn more here.

Analysis Model and Snowflake

Details of the analysis model used to generate this report is available on our Github page, we also have guides on how to use our reports and tutorials on Youtube.

Learn about the world class team who designed and built the Simply Wall St analysis model.

Industry and Sector Metrics

Our industry and section metrics are calculated every 6 hours by Simply Wall St, details of our process are available on .

Analyst Sources

Trajan Group Holdings Limited is covered by 2 analysts. 2 of those analysts submitted the estimates of revenue or earnings used as inputs to our report. Analysts submissions are updated throughout the day.

Analyst	Institution
Elyse Shapiro	Canaccord Genuity
Phillip Chippindale	Ord Minnett Limited

Trajan Group Holdings OTCPK:TRJN.F Stock Report